Amgen Inc. on Tuesday said it signed a deal to sell a a development and manufacturing facility in Fremont to German drugmaker Boehringer Ingelheim.

Thousand Oaks-based Amgen obtained the facility in its 2006 acquisition of Abgenix. Amgen said it will continue to have a presence in the San Francisco Bay Area biotech community through its South San Francisco research facility.

The 100,000-square-foot manufacturing facility employs about 360 workers, who will join Boehringer, which does some contract manufacturing for Amgen. Financial terms were not disclosed.

CLICK HERE to read the RTT News story.

For reprint and licensing requests for this article, CLICK HERE.